ArticleBMC ophthalmology2025
Granulomatosis with polyangiitis presenting as axial proptosis and corneal perforation-a case report.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Case Report of Granulomatosis with Polyangiitis Presenting with Chronic Conjunctivitis.Journal of education & teaching in emergency medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGranulomatosis with polyangiitis (GPA) is a rare, aggressive, and rapidly progressive multisystem disease that primarily affects the respiratory tract, kidneys, and vascular system. Although less common, GPA can affect the eye through corneal involvement, scleral inflammation, and orbital mass formation. This report highlights a case in which sudden axial proptosis and corneal perforation revealed underlying GPA. CASE PRESENTATION: A 32-year-old female presented with a 20-day history of painful left eye proptosis, purulent discharge, photophobia, and progressive vision loss, which eventually led to no perception of light at presentation. She also reported recurrent episodes of congestion in both eyes over two years, intermittent episodes of haematuria, and chronic cough. On general examination, she was conscious and oriented to time, place, and person. Her vital signs were stable; however, she had pallor and bilateral chest crepitations. Ophthalmic examination revealed 6/6 vision in the right eye; however, the patient denied perceiving light in the left eye. The left eye exhibited axial proptosis, conjunctival congestion, chemosis, and a small corneal perforation with iris prolapse and a flat anterior chamber. A B-scan ruled out endophthalmitis, suggesting a non-infectious aetiology. On further imaging, CT orbit revealed a lacrimal fossa pseudotumor causing proptosis. HRCT of the chest revealed multiple cavitating lung nodules in both lungs. Systemic evaluation revealed normocytic normochromic anaemia, leucocytosis, thrombocytosis, elevated ESR (87 mm/hr), CRP (156 mg/L), and rheumatoid factor (184 IU/mL). Urinalysis revealed haematuria and proteinuria, suggesting renal involvement. ANCA ELISA was strongly positive for anti-PR3 (338 U/mL), confirming a diagnosis of granulomatosis with polyangiitis (GPA). She was treated with topical and intravenous antibiotics and tissue adhesive with bandage contact lens application for corneal perforation. Systemic immunosuppression was achieved with intravenous methylprednisolone and cyclophosphamide. She was discharged on oral steroids with scheduled follow-up visits in the ophthalmology and rheumatology departments.
conclusionThis case highlights the importance of recognizing ocular signs as potential indicators of systemic vasculitis. Thus, timely diagnosis can help avert life-threatening systemic complications, thereby minimizing both the morbidity and mortality of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.